Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShort-term InvestmentsWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Cash & Current Investments: 2020-2024

Historic Cash & Current Investments for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to $71.5 million.

  • Burning Rock Biotech's Cash & Current Investments fell 25.21% to $65.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.6 million, marking a year-over-year decrease of 25.21%. This contributed to the annual value of $71.5 million for FY2024, which is 17.44% down from last year.
  • Latest data reveals that Burning Rock Biotech reported Cash & Current Investments of $71.5 million as of FY2024, which was down 17.44% from $86.7 million recorded in FY2023.
  • Burning Rock Biotech's 5-year Cash & Current Investments high stood at $346.0 million for FY2020, and its period low was $71.5 million during FY2024.
  • For the 3-year period, Burning Rock Biotech's Cash & Current Investments averaged around $97.4 million, with its median value being $86.7 million (2023).
  • Its Cash & Current Investments has fluctuated over the past 5 years, first plummeted by 42.82% in 2022, then rose by 17.44% in 2024.
  • Over the past 5 years, Burning Rock Biotech's Cash & Current Investments (MRY) stood at $346.0 million in 2020, then plummeted by 32.19% to $234.6 million in 2021, then crashed by 42.82% to $134.2 million in 2022, then crashed by 35.41% to $86.7 million in 2023, then fell by 17.44% to $71.5 million in 2024.
  • Its last three reported values are $71.5 million in FY2024, $86.7 million for FY2023, and $134.2 million during FY2022.